Pfizer Inc 23 March 2017 Cancellation of Listing 23 March 2017 Pfizer Inc. (NYSE:PFE) (the "Company") announces that at 8:00 a.m...
Pfizer Inc 01 March 2017 Media Relations Contact: March 1, 2017 Joan Campion 212-733-2798 Investor Relations Contact: Ryan Crowe 212-733-8160 It...
Pfizer Inc 27 February 2017 Media Relations Contact: February 27, 2017 Joan Campion 212-733-2798 Investor Relations Contact: Ryan Crowe...
Pfizer Inc 24 February 2017 Media Contact: February 24, 2017 Joan Campion (212) 733-2798 joan.campion@pfizer.com Investor Contact: Bryan Dunn...
Pfizer Inc 22 February 2017 Pfizer Inc. to cancel listing in the United Kingdom 22 February 2017 Pfizer Inc. (NYSE:PFE) (the "Company"...
Pfizer Inc 31 January 2017 Pfizer Inc 31(st) January 2017 Re: Fourth Quarter and Full-Year 2016 Results Please click on the following link to...
JPMorgan Asset Management 24 November 2015 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
BlackRock Group 24 November 2015 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
J.P. Morgan Securities LLC 24 November 2015 Ap27 FORM 38.5(b) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT...
JPMorgan Securities Plc 24 November 2015 Ap9 APPENDIX 3 DISCLOSURE FORMS FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads